7T2V
SARS CoV2 Mpro C145S mutant
7T2V の概要
エントリーDOI | 10.2210/pdb7t2v/pdb |
分子名称 | 3C-Like Protease (2 entities in total) |
機能のキーワード | sars-cov2 2c-like protease, mpro, 2clpro, c145s mutation, hydrolase |
由来する生物種 | Severe acute respiratory syndrome coronavirus 2 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 142257.58 |
構造登録者 | |
主引用文献 | Hameedi, M.A.,T Prates, E.,Garvin, M.R.,Mathews, I.I.,Amos, B.K.,Demerdash, O.,Bechthold, M.,Iyer, M.,Rahighi, S.,Kneller, D.W.,Kovalevsky, A.,Irle, S.,Vuong, V.Q.,Mitchell, J.C.,Labbe, A.,Galanie, S.,Wakatsuki, S.,Jacobson, D. Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro. Nat Commun, 13:5285-5285, 2022 Cited by PubMed Abstract: In addition to its essential role in viral polyprotein processing, the SARS-CoV-2 3C-like protease (3CLpro) can cleave human immune signaling proteins, like NF-κB Essential Modulator (NEMO) and deregulate the host immune response. Here, in vitro assays show that SARS-CoV-2 3CLpro cleaves NEMO with fine-tuned efficiency. Analysis of the 2.50 Å resolution crystal structure of 3CLpro C145S bound to NEMO reveals subsites that tolerate a range of viral and host substrates through main chain hydrogen bonds while also enforcing specificity using side chain hydrogen bonds and hydrophobic contacts. Machine learning- and physics-based computational methods predict that variation in key binding residues of 3CLpro-NEMO helps explain the high fitness of SARS-CoV-2 in humans. We posit that cleavage of NEMO is an important piece of information to be accounted for, in the pathology of COVID-19. PubMed: 36075915DOI: 10.1038/s41467-022-32922-9 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.47 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
